Video summary
A 10 Bagger Like These Stocks May Never Happen Again
Main summary
Key takeaways
Core thesis / market context
- The speaker argues the market is in a “stock pickers market” regime where a small group of stocks drives most gains, while many laggards drag on broad indexes.
- Quant claim: 77% of S&P 500 gains in the year come from the top 12 stocks, implying high dispersion and extreme “winners vs losers” divergence.
- Observed setup signals:
- Small caps dispersion: Russell 2000 has “done nothing” for ~2 years, but top vs bottom small caps dispersion ~2x, creating opportunities for stock-specific catalysts.
- Dense catalyst calendar in an unnamed cluster of 4 sectors/themes (notably: FDA/regulatory, contracts, tech milestones).
- Institutional positioning: institutions are buying early (framed as a “fingerprint”), before mainstream retail catches on.
Explicit timeline and target timeframe
- The list is framed as having a chance at “10xer” outcomes within the next 12 months.
Methodology / framework (step-by-step logic)
The presenter(s) describe a rule-based selection approach using an app/screening tool:
1) Themes / flows screen (4 money flows)
Identify companies downstream of 4 money flows:
- Hard assets / anti-inflation trade
- Commodities (e.g., mining)
- “War stocks” / defense & national security
- Contract-driven small caps
- Quantum
- Commercial scale revenues after a long wait; governments treat as strategic
- “Looney” / mental health
- A new FDA-approved drug class in ~40 years (psilocybin-related therapy)
2) Company filters (risk/quality checks)
- “Moat” proxy: how much of each revenue dollar remains after costs
- Target for this analysis is ~70%+
- The chosen names are not yet at that level → implies higher risk / earlier stage
- Growth/profit trend check (last 4 quarters):
- red = declining
- orange = improving
- (hover description noted in subtitles)
- They emphasize three conditions for a plausible 10x:
- Small enough company size
- Claimed “math zone” is $1B to $10B market cap
- Larger cases (e.g., $100B → $1T in 12 months) are described as extremely unlikely
- A real event catalyst
- Examples: FDA approval, government contract, tech milestone, profitability turning point
- Timing
- Institutional money begins moving before retail hype
- By the time mainstream coverage rises, “the trade may be over.”
- Small enough company size
Disclosures / cautions stated
- Explicit “not financial advice” is not clearly stated, but multiple disclaimers appear, including:
- “I don’t have a crystal ball”
- Past performance is no guarantee
- Need to do your own research and “know the rules”
- Warning: copying the list without understanding the rules can lead to losses
- Risk sizing guidance (position sizing):
- Typically 1% to 3% max of a total portfolio for these speculative bets
- Rationale: define/limit downside (“controlled downside” / “define your downside”)
- Example volatility callout: Big Bear AI noted as down ~30% in a single day → size accordingly
Tickers / assets mentioned and what they’re tied to
The 6 “10-bagger-like” candidates (explicit list)
-
Regetti Computing (ticker not clearly formatted in subtitles) — “Regetti”
- Quantum computing hardware/software story
- Catalysts mentioned:
- Lyra chip launch later this year
- $100M UK government contract
- $8M India contract
- $250M contract (context unclear)
- Nvidia platform integration
-
D-Wave — QBTS
- Quantum annealing; optimization-oriented
- Key metrics:
- ~65% gross margin range
- Customers cited:
- 135 customers (including LG, Sharp, and Andural)
- Catalysts:
- Investor day in June
- Revenue cited as ~$25M last year, “growing quickly”
-
INQ — INQ
- Gate-model quantum; framed as a revenue leader
- Metrics:
- $62M revenue last quarter
- ~428% YoY revenue growth
- Guided > $200M revenue this year
- Catalysts:
- $1.8B acquisition of SkyWater
- DMEA category 1 approval (US military/defense agency chips)
- “~80% revenue from commercial customers”
-
Compass Pathways — CMPS
- Mental health / psilocybin therapy
- Pipeline:
- COMP360
- Phase 2: treatment-resistant depression
- Phase 2: PTSD
- Subtitles context:
- “no margins / no sales / nothing at all” yet → very early stage
- IPO context:
- IPO around $17 in 2020, ran to ~$60, then dropped below $4
-
Compass Minerals — CMP
- Salt and specialty fertilizer producer (potash/sulfate referenced)
- “Hard asset” framing; described as not disrupted by AI
- Catalysts:
- Fertilizer prices “going through the roof”
- “Earnings just came in a little bit better” → stock popped
- Valuation/price context:
- Peak ~$100
- “around $30 right now” (approx.)
- Balance sheet context:
- improving debt restructuring
- debt-to-equity improving
- Market cap:
- noted as about $1B
-
Big Bear AI — BBAI
- Defense/national security + AI analytics
- Money flows:
- AI compute spending
- war/defense spending
- Catalysts:
- “several new contracts over the next several quarters”
- NATO rearmament mentioned
- shift to US AI vendors
- Risk:
- margins “suck”; volatility
- market cap described as fluctuating ~$1B to $3B
- Performance risk callout:
- down ~30% in a single day
Other tickers referenced as cautionary examples (past hype cycle)
Used to illustrate “buy and hold died” / rotation out after stories change:
- PayPal — peak ~$310, down ~85% (also mentioned around ~$40-ish trading level)
- Plug Power — peak ~$75, down ~96%
- BlackBerry — peak ~$28, down ~77%
- NEO — peak ~$67, down ~90%
- Lucid — described similarly (exact numbers not provided)
- Seagate (not a “current candidate”)
- cited as $95, then touched $100 ~12 months later
- described as ~745% gain (implied prior call price unclear in subtitles)
- Palantir
- mentioned as an earlier call that ran ~600%
Index / macro instruments and sectors
- S&P 500: top 12 stocks contribute 77% of gains
- Russell 2000: small caps; index described as flat “nothing for two years” while dispersion rises
- Themes mentioned (part of app categories):
- quantum computing
- cyber/security/AI/robotics
- uranium
- satellites/space
- (not tied to specific tickers beyond the 6 candidates above)
Key performance metrics & numbers (as stated)
- “10x next 12 months” target
- Historical examples of outperformance (evidence, not guarantees):
- Regetti: “up over 1,000%”
- D-Wave: “about 800%”
- INQ: “tripled”
- Palantir: “ran up 600%”
- “Buy and hold” critique with drawdown examples:
- PayPal: peak 310, trading around $40-ish, down ~85%
- Plug Power: peak 75, down ~96%
- BlackBerry: peak 28, down ~77%
- NEO: peak 67, down ~90%
- Selection metrics / growth & margins:
- D-Wave gross margin: ~65% range
- INQ revenue: $62M last quarter; ~428% YoY; guided > $200M this year
- Regetti profit growth cited:
- last quarter profits up 90%
- growth up 93% (also noted as 90/93% for Regetti)
- INQ profit growth cited: up 329%
- CMPS profit growth cited: “went down 59%” (but still “better than quarter before”)
- CMP profit growth cited: up 177%
- BBAI profit growth cited: up 98%
- Portfolio construction / risk:
- Speculative allocation: 1%–3% max per position
- Example volatility: BBAI down ~30% in a single day
- Commodities macro linkage:
- Fertilizer prices linked to Middle East developments as a driver of “through the roof” fertilizer prices
Presenters / sources mentioned
- Felix — speaker (“my name is Felix”)
- Winston — co-speaker/analyst
- “does all the hard thinking”
- referenced as building the “Winston app” and providing research
- Background note:
- “we used to be investment bankers”
- No additional named sources beyond Felix/Winston were provided
Notes on formatting in subtitles (data quality)
- Regetti computing ticker formatting is unclear in subtitles.
- Some contract figures (e.g., the $250M for Regetti) have unclear context.
- Lucid and Seagate include descriptive numbers but not all inputs (exact prior call price for the Seagate “~745% gain”) are fully specified in subtitles.